Maurice Zauderer

2.1k total citations · 1 hit paper
72 papers, 1.4k citations indexed

About

Maurice Zauderer is a scholar working on Immunology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Maurice Zauderer has authored 72 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Immunology, 26 papers in Cellular and Molecular Neuroscience and 20 papers in Molecular Biology. Recurrent topics in Maurice Zauderer's work include Axon Guidance and Neuronal Signaling (24 papers), T-cell and B-cell Immunology (18 papers) and Immune Cell Function and Interaction (15 papers). Maurice Zauderer is often cited by papers focused on Axon Guidance and Neuronal Signaling (24 papers), T-cell and B-cell Immunology (18 papers) and Immune Cell Function and Interaction (15 papers). Maurice Zauderer collaborates with scholars based in United States, United Kingdom and Switzerland. Maurice Zauderer's co-authors include Ernest Smith, Corrado Baglioni, Elizabeth E. Evans, Christine Reilly, Ilan Bleiberg, Alan S. Jonason, Terrence L. Fisher, D A Faherty, Laurie A. Winter and Mark Paris and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Maurice Zauderer

70 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A biological classification of Huntington's disease: the Integrated Staging System

2022 142 citations Sarah J. Tabrizi, Scott Schobel et al. The Lancet Neurology profile →

Peers

Countries citing papers authored by Maurice Zauderer

Since Specialization

Citations

This map shows the geographic impact of Maurice Zauderer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maurice Zauderer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maurice Zauderer more than expected).

Fields of papers citing papers by Maurice Zauderer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maurice Zauderer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maurice Zauderer. The network helps show where Maurice Zauderer may publish in the future.

Co-authorship network of co-authors of Maurice Zauderer

This figure shows the co-authorship network connecting the top 25 collaborators of Maurice Zauderer. A scholar is included among the top collaborators of Maurice Zauderer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maurice Zauderer. Maurice Zauderer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Pepinemab: a SEMA4D antagonist for treatment of Huntington’s and other neurodegenerative diseases 2025 ·Expert Opinion on Investigational Drugs ·Andrew Feigin, Elizabeth E. Evans, Terrence L. Fisher, Maurice Zauderer	1
2	Conclusions of the SIGNAL study in Huntington and implications for treatment of other slowly progressive neurodegenerative diseases 2023 ·Clinical and Translational Medicine ·Maurice Zauderer, Elizabeth E. Evans	6
3	SEMA4D blocking antibody, pepinemab, is a novel potential treatment for neurodegenerative disease: Clinical proof of concept in Phase 2 HD study supports ongoing clinical development in Phase 1/2 AD study 2023 ·Alzheimer s & Dementia ·Terrence L. Fisher, Elizabeth E. Evans, (unknown), (unknown), Vikas Mishra, Crystal Mallow, Ernest Smith, John E. Leonard, Andrew Feigin, Eric Siemers, Kimberly A. Walters, (unknown), Scott Turner, Martin R. Farlow, Maurice Zauderer	1
4	A biological classification of Huntington's disease: the Integrated Staging System breakdown → 2022 ·The Lancet Neurology ·Sarah J. Tabrizi, Scott Schobel, Emily C. Gantman, (unknown), Beth Borowsky, Pavlina Konstantinova, Tiago Mestre, Jennifer Panagoulias, Christopher A. Ross, Maurice Zauderer, Ariana P. Mullin, Klaus Romero, Sudhir Sivakumaran, Emily C. Turner, Jeffrey D. Long, Cristina Sampaio	142
5	Semaphorin4D Inhibition Improves Response to Immune-Checkpoint Blockade via Attenuation of MDSC Recruitment and Function 2018 ·Cancer Immunology Research ·Paúl E. Clavijo, Jay Friedman, Yvette Robbins, Ellen Moore, Ernest Smith, Maurice Zauderer, Elizabeth E. Evans, Clint Allen	40
6	Nonclinical Safety Evaluation of VX15/2503, a Humanized IgG4 Anti-SEMA4D Antibody 2015 ·Molecular Cancer Therapeutics ·John E. Leonard, Terrence L. Fisher, Laurie A. Winter, (unknown), Christine Reilly, Ernest Smith, Maurice Zauderer	31
7	Safety, Pharmacokinetics, and Pharmacodynamics of a Humanized Anti-Semaphorin 4D Antibody, in a First-In-Human Study of Patients with Advanced Solid Tumors 2015 ·Clinical Cancer Research ·Amita Patnaik, Glen J. Weiss, John E. Leonard, Drew Rasco, Jasgit C. Sachdev, Terrence L. Fisher, Laurie A. Winter, Christine Reilly, Robert B. Parker, (unknown), Lisa Blaydorn, Anthony W. Tolcher, Maurice Zauderer, Ramesh K. Ramanathan	50
8	Antibody Blockade of Semaphorin 4D Promotes Immune Infiltration into Tumor and Enhances Response to Other Immunomodulatory Therapies 2015 ·Cancer Immunology Research ·Elizabeth E. Evans, Alan S. Jonason, Holm Bußler, Sebold Torno, Janaki Veeraraghavan, Christine Reilly, (unknown), (unknown), Laurie A. Winter, Crystal Mallow, (unknown), Alan Howell, (unknown), (unknown), (unknown), Terrence L. Fisher, William J. Bowers, Mark Paris, Ernest Smith, Maurice Zauderer	88
9	Anti-semaphorin 4D immunotherapy ameliorates neuropathology and some cognitive impairment in the YAC128 mouse model of Huntington disease 2015 ·Neurobiology of Disease ·Amber L. Southwell, Sonia Franciosi, Erika B. Villanueva, Yuanyun Xie, Laurie A. Winter, Janaki Veeraraghavan, Alan S. Jonason, (unknown), Weining Zhang, (unknown), Sabine Waltl, George Hall, Mahmoud A. Pouladi, Ernest Smith, William J. Bowers, Maurice Zauderer, Michael R. Hayden	87
10	Generation and preclinical characterization of an antibody specific for SEMA4D 2015 ·mAbs ·Terrence L. Fisher, Christine Reilly, Laurie A. Winter, (unknown), Alan S. Jonason, (unknown), (unknown), Holm Bußler, Sebold Torno, (unknown), Loretta Mueller, He Huang, Ekaterina Klimatcheva, Alan Howell, (unknown), Elizabeth E. Evans, Mark Paris, John E. Leonard, Ernest Smith, Maurice Zauderer	36
11	CXCL13 antibody for the treatment of autoimmune disorders 2015 ·BMC Immunology ·Ekaterina Klimatcheva, (unknown), Christine Reilly, Sebold Torno, Holm Bußler, (unknown), Alan S. Jonason, Crystal Mallow, Michael Doherty, Mark Paris, Ernest Smith, Maurice Zauderer	94
12	Anti-CXCL13 antibody can inhibit the formation of gastric lymphoid follicles induced by Helicobacter infection 2014 ·Mucosal Immunology ·Koji Yamamoto, Shin Nishiumi, (unknown), Ekaterina Klimatcheva, (unknown), Shinʼichi Takahashi, Hidenori Matsui, Masahiko Nakamura, Maurice Zauderer, Masaru Yoshida, Takeshi Azuma	38
13	Maximizing Immune Responses: The Effects of Covalent Peptide Linkage to Beta-2-Microglobulin 2008 ·Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics ·Stephen M. Bauer, Marc A. Williams, Alan Howell, Edward M. Schwarz, Ernest Smith, Maurice Zauderer	2
14	C35 (C17orf37) is a novel tumor biomarker abundantly expressed in breast cancer 2006 ·Molecular Cancer Therapeutics ·Elizabeth E. Evans, (unknown), Alan S. Jonason, Mark Paris, Linda Schiffhauer, Melinda A. Borrello, Ernest Smith, Deepak M. Sahasrabudhe, Maurice Zauderer	43
15	In vitro generation of tumor specific T cells that recognize a shared antigen of AML: Molecular characterization of TCR genes 2006 ·Leukemia Research ·Myra Coppage, Todd Belanger, Maurice Zauderer, Deepak M. Sahasrabudhe	2
16	Prior exposure of mice to Fusobacterium nucleatum modulates host response to Porphyromonas gingivalis 2001 ·Oral Microbiology and Immunology ·Jeom‐Il Choi, Melinda A. Borrello, Smith Eh, Christopher W. Cutler, Hakimuddin T. Sojar, Maurice Zauderer	24
17	Construction and Characterization of Vaccinia Direct Ligation Vectors 1997 ·Virology ·Michael Merchlinsky, (unknown), Ernest Smith, Maurice Zauderer	21
18	Shared T cell-defined antigens on independently derived tumors. 1993 ·The Journal of Immunology ·Deepak M. Sahasrabudhe, (unknown), (unknown), Barbara Hibner, John Leslie Collins, Maurice Zauderer	4
19	Gamma gene rearrangement and expression in autoreactive helper T cells. 1986 ·The Journal of Experimental Medicine ·Maurice Zauderer, Aikichi Iwamoto, Tak W. Mak	28
20	Clonal analysis of F1 hybrid helper T cells restricted to parental or F1 hybrid major histocompatibility determinants. 1980 ·The Journal of Experimental Medicine ·(unknown), Michael J. Imperiale, Maurice Zauderer	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact